第一医药: 上海第一医药股份有限公司2024年年度股东大会会议资料

Core Points - The Shanghai First Pharmaceutical Co., Ltd. will hold its 2024 Annual General Meeting on June 20, 2025, with both on-site and online voting options available for shareholders [1][2][3] - The meeting will cover 12 proposals, including the annual report, board and supervisory reports, financial statements, and various governance matters [6][7][15] - The company emphasizes maintaining shareholder rights and ensuring orderly conduct during the meeting [4][5] Meeting Agenda - The meeting will start with attendance reporting and the announcement of the meeting's commencement [1] - Proposals will be read and discussed, followed by independent directors' reports and shareholder Q&A sessions [1][3] - Voting will occur after discussions, with results announced by the legal representative [1][6] Voting Procedures - Shareholders must present valid identification and may appoint proxies with proper authorization to vote [2][4] - Voting will be conducted through both on-site and online methods, with specific time frames for each [4][5] - Each proposal will be voted on individually, and any invalid votes will be counted as abstentions [5][6] Board and Supervisory Reports - The board's report will detail the company's operations and governance practices, highlighting compliance with legal and regulatory requirements [7][8][10] - The supervisory report will confirm the company's adherence to laws and regulations, ensuring the protection of shareholder interests [15][17] Financial Overview - The financial report for 2024 will be presented, including audited financial statements and budget proposals for 2025 [22] - The company has received a standard unqualified audit opinion from its accounting firm [22]